Anti-UPK3A/ UP3A/ UPIII monoclonal antibody

Anti-UPK3A/ UP3A/ UPIII antibody for FACS & in-vivo assay

Target products collectionGo to UPK3A/UPK3A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1908-Ab-1/ GM-Tg-hg-MP1908-Ab-2Anti-Human UPK3A monoclonal antibodyHuman
GM-Tg-rg-MP1908-Ab-1/ GM-Tg-rg-MP1908-Ab-2Anti-Rat UPK3A monoclonal antibodyRat
GM-Tg-mg-MP1908-Ab-1/ GM-Tg-mg-MP1908-Ab-2Anti-Mouse UPK3A monoclonal antibodyMouse
GM-Tg-cynog-MP1908-Ab-1/ GM-Tg-cynog-MP1908-Ab-2Anti-Cynomolgus/ Rhesus macaque UPK3A monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1908-Ab-1/ GM-Tg-felg-MP1908-Ab-2Anti-Feline UPK3A monoclonal antibodyFeline
GM-Tg-cang-MP1908-Ab-1/ GM-Tg-cang-MP1908-Ab-2Anti-Canine UPK3A monoclonal antibodyCanine
GM-Tg-bovg-MP1908-Ab-1/ GM-Tg-bovg-MP1908-Ab-2Anti-Bovine UPK3A monoclonal antibodyBovine
GM-Tg-equg-MP1908-Ab-1/ GM-Tg-equg-MP1908-Ab-2Anti-Equine UPK3A monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1908-Ab-1/ GM-Tg-hg-MP1908-Ab-2; GM-Tg-rg-MP1908-Ab-1/ GM-Tg-rg-MP1908-Ab-2;
GM-Tg-mg-MP1908-Ab-1/ GM-Tg-mg-MP1908-Ab-2; GM-Tg-cynog-MP1908-Ab-1/ GM-Tg-cynog-MP1908-Ab-2;
GM-Tg-felg-MP1908-Ab-1/ GM-Tg-felg-MP1908-Ab-2; GM-Tg-cang-MP1908-Ab-1/ GM-Tg-cang-MP1908-Ab-2;
GM-Tg-bovg-MP1908-Ab-1/ GM-Tg-bovg-MP1908-Ab-2; GM-Tg-equg-MP1908-Ab-1/ GM-Tg-equg-MP1908-Ab-2
Products NameAnti-UPK3A monoclonal antibody
Formatmab
Target NameUPK3A
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-UPK3A benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species UPK3A/ UP3A/ UPIII VLP (virus-like particle) (Products Developing)
    ORF Viral VectorvGMLP004984human UPK3A Lentivirus particle
    ORF Viral VectorpGMLP004984human UPK3A Lentivirus plasmid
    ORF Viral VectorpGMLPm001933mouse Upk3a Lentivirus plasmid
    ORF Viral VectorvGMLPm001933mouse Upk3a Lentivirus particle


    Target information

    Target IDGM-MP1908
    Target NameUPK3A
    Gene ID7380,22270,315190,717456,609118,101088858,100336102,100052016
    Gene Symbol and Synonyms1110017C07Rik,UP3A,UPIII,UPIIIA,UPK3,UPK3A
    Uniprot AccessionO75631,P38574
    Uniprot Entry NameUPK3A_HUMAN,UPK3A_BOVIN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseMalignant neoplasm of bladder
    Gene EnsemblENSG00000100373
    Target ClassificationN/A

    The target: UPK3A, gene name: UPK3A, also named as UP3A, UPIII, UPIIIA, UPK3. This gene encodes a member of the uroplakin family, a group of transmembrane proteins that form complexes on the apical surface of the bladder epithelium. Mutations in this gene may be associated with renal adysplasia. Alternatively spliced transcript variants have been described.[provided by RefSeq, Nov 2009].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.